BackTable Urology BackTable

In this episode of the BackTable Urology, Dr. Bogdana Schmidt (University of Utah), Dr. Woodson Smelser (Washington University in St. Louis), and Dr. Jeff Tosoian (Vanderbilt University) discusses the latest insights and advancements in prostate and bladder cancer treatment presented at AUA 2024.

---

CHECK OUT OUR SPONSOR

Veracyte
https://www.veracyte.com/decipher

---

SYNPOSIS

First, the doctors cover noteworthy topics, including the effectiveness of early screening and treatment for high-risk prostate cancer patients, innovative approaches in imaging and biomarkers, and the impact of new guidelines on salvage therapy. They also explore emerging treatments for non-muscle invasive bladder cancer (NMIBC), as well as the evolving role of systemic immunotherapies and advanced genomic testing. To wrap up, the urologists offer detailed analyses and their expert opinions on how these developments could transform patient care in the field of urologic oncology.

---

TIMESTAMPS

00:00 - Introductions
03:06 - Prostate Cancer Screening Insights
10:10 - Advancements in MRI and Biomarkers
18:22 - Transperineal vs. Transrectal Prostate Biopsy
27:18 - New Guidelines for Bladder Cancer Treatment
30:57 - Innovative Drug Delivery Systems
32:36 - Gene Therapy and Immunotherapy Advances
40:11 - Concluding Thoughts and Future Prospects

---

RESOURCES

Decipher Prostate Genomic Classifier by Veracyte:
​​https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/

In this episode of Back Table Urology, Dr. Aditya Bagrodia, Dr. Joshua Langston, and Dr. Mara Holton from the Large Urology Group Practice Association (LUGPA) share insights on the financial and administrative complexities that urologists face.

---

CHECK OUT OUR SPONSOR

Fellow
https://www.meetfellow.com/

---

SYNPOSIS

The doctors delve into the increasing costs of healthcare, the challenges posed by regulatory requirements, and the significance of physician leadership in influencing healthcare delivery. The discussion also highlights the importance of advocacy, the evolving role of physicians in business and policy, and actionable steps doctors can take to ensure their voices are heard. Finally, the doctors address the growing trend of hospital employment among physicians and its impact on rural healthcare access.

---

TIMESTAMPS

00:00 - Introduction
06:41 - Complexities and Costs in Healthcare
11:48 - The Role of Physicians in Healthcare Leadership
17:21 - The Shift Towards Hospital Employment
27:35 - Economic Pressures on Physicians and Patients
30:09 - Cost Discrepancies in Medical Procedures
38:16 - Burnout and Workforce Challenges
49:26 - Advocacy and Call to Action

---

RESOURCES

Fellow
https://www.meetfellow.com/

BackTable URO Ep. 82- Advocacy Basics for the Urologist: From Your Clinic to Capitol Hill with Dr. Ruchika Talwar
https://open.spotify.com/episode/0hcLrKuf5QU7TZCHSErs4Z?si=842c7985f44c4e04

BackTable URO Ep. 164: Urology Advocacy: From Passion to Policy with Dr. Seth Cohen, Dr. Michelle Leach, and Dr. Suzette Sutherland
https://open.spotify.com/episode/68pR7MxFIgQ1HJLy6xQHDX?si=36a93eedd6594770

In this episode of BackTable Urology, host Dr. Aditya Bagrodia, urologic oncologist Dr. Philippe Speiss (Moffitt Cancer Center), and medical oncologist Dr. Andrea Necchi (Università Vita-Salute San Raffaele) have an in-depth discussion about the mission and achievements of the Global Society of Rare Genitourinary Tumors (GSRGT).

---

CHECK OUT OUR SPONSORS

Siemens Healthineers Theranostics
https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

Veracyte
https://www.veracyte.com/decipher

---

SYNPOSIS

First, the doctors discuss the society’s mission to improve the diagnosis and treatment of rare genitourinary cancers globally. They give an overview of their educational efforts, international collaborations, and significant achievements in clinical research. The discussion also covers the importance of global representation, the challenges of studying rare tumors, and future directions, such as leveraging artificial intelligence. The episode concludes with an emphasis on the society’s commitment to being inclusive and providing opportunities for young investigators.

---

TIMESTAMPS

00:00 - Introduction
06:45 - Origins and Missions of GSRGT
11:21 - Challenges in Rare Cancer Research
31:51 - Future Directions in Rare Cancer Treatment
38:38 - How to Get Involved with GSRGT

---

RESOURCES

Siemens Healthineers Theranostics:
https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

Decipher Prostate Genomic Classifier by Veracyte:
​​https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/

GSRGT Website
https://www.gsrgt.com/

Andrea Necchi Website
https://www.andreanecchi.com/

In this episode, Dr. Matthew Cooperberg (UC San Francisco) and Dr. Arvin George (Johns Hopkins) join host Dr. Aditya Bagrodia in a conversation about guidelines and treatment algorithms for focal therapy in prostate cancer treatment.

---

CHECK OUT OUR SPONSORS

Siemens Healthineers Theranostics
https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

Veracyte
https://www.veracyte.com/decipher

---

SYNPOSIS

First, the doctors discuss focal therapy in prostate cancer treatment from various perspectives, including the challenges of treating certain lesions, the comparison of different focal therapy modalities like high-intensity focused ultrasound (HIFU) and brachytherapy, cryotherapy and the importance of patient-specific factors in treatment decisions. They emphasize the need for clinical trials and registries to validate focal therapy outcomes, the potential expansion of indications for focal therapy, and the critical role of advanced imaging and genomic classifiers in patient selection and treatment planning. The discussion also touches on the potential of focal therapy to evolve as a standard care option alongside advancements in understanding the biology of prostate cancer and improving imaging and treatment technologies.

---

TIMESTAMPS

Siemens Healthineers Theranostics:
https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

Decipher Prostate Genomic Classifier by Veracyte:
​​https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/

---

RESOURCES

Siemens Healthineers Theranostics:
https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

Decipher Prostate Genomic Classifier by Veracyte:
​​https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/

In this episode of Backtable Urology Podcast, Ken Mitchell MPAS, PA-C, a certified physician associate, speaks about the role of interprofessional collaboration in treating male sexual dysfunction and infertility.

---

CHECK OUT OUR SPONSOR

KYZATREX™
https://www.kyzatrex.com

---

SYNPOSIS

First, Ken highlights his journey into men’s health, sparked by the debut of erectile dysfunction medication and his engagement in vascular medicine. He then discusses how he leveraged his clinical background to address prevalent issues such as erectile dysfunction and testosterone management. Ken emphasizes the importance of education, collaboration, and innovative treatment approaches in providing effective patient care. Dr. Silva and Ken also cover the potential of oral testosterone treatments and their growing acceptance among patients due to convenience and cost-effectiveness. Ken shares insights into his role in advancing APP utilization in urology practices and ensuring comprehensive care coverage. Finally, Ken introduces his nonprofit organization, GUYnecology Men’s Health, an initiative aimed at fostering a broader understanding of preventative care among patients and healthcare professionals.

---

TIMESTAMPS

00:00 - Introduction
06:28 - Expanding the Role of APPs in Urology
14:47 - Addressing Testosterone Replacement Therapy
21:40 - Exploring Treatment and Insurance Challenges in Urology Practices
27:35 - The Evolution of Oral Testosterone Treatments
35:29 - Incorporating Telehealth and Enhancing Patient Education
36:03 - Introducing Guynecology: A New Approach to Men’s Health
41:44 - Final Thoughts and Advice for Urologists and APPs

---

RESOURCES

KYZATREX
https://www.kyzatrex.com/

GUYnecology Men’s Health Association
https://learnguynecology.org/

In this episode of BackTable Urology, Dr. James Smith, Director of Male Reproductive Health at UC San Francisco and CMO of Fellow, discusses advancements in semen analysis and fertility testing with Dr. Jose Silva.

---

CHECK OUT OUR SPONSOR

Fellow
https://www.meetfellow.com/

---

SYNPOSIS

First, Dr. Smith introduces the significance of a comprehensive approach to examining male fertility, including total motile sperm counts and treatable conditions like prostatitis. He also highlights the role of the Fellow kit, a mail-in semen analysis test that improves the access and availability of sperm analysis. He explains the scientific foundations behind the Fellow kit, including temperature control, nutrient supply, and antibacterial measures to preserve sperm motility. The episode also touches on broader themes in fertility, such as the impact of illnesses like COVID-19 on sperm quality, the potential for future molecular and genetic testing in semen analysis, and the socioeconomic factors affecting access to fertility testing. Finally, Dr. Smith emphasizes the importance of early and comprehensive fertility evaluations for men and discusses the potential for future research to further improve fertility diagnostics.

---

TIMESTAMPS

0:00 - Exploring Fertility Challenges and Solutions
10:16 - The Game-Changing Impact of the Fellow Semen Analysis Kit
15:29 - Navigating Semen Analysis: Quality, Progression, and Treatment
22:51 - The Importance of Early Fertility Testing and Intervention
27:27 - The Journey of Fellow: Improving Patient Compliance and Access
41:08 - The Future of Semen Analysis and Fertility Research
44:25 - Concluding Thoughts on Male Fertility and Patient Care

---

RESOURCES

Fellow Website
https://www.meetfellow.com/